Skip to main content Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
Aug 13, 2021 8:50am EDT

Recro Announces Acquisition of San Diego-based IRISYS, Creating Bi-Coastal, Full Service CDMO

Aug 10, 2021 7:00am EDT

Recro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMO

Aug 09, 2021 4:05pm EDT

Recro Reports Second Quarter 2021 Financial Results

Aug 02, 2021 4:05pm EDT

Recro To Report Financial Results for Second Quarter 2021 on August 9, 2021

Jul 20, 2021 7:00am EDT

Recro Appoints Erica Raether as Vice President of People, Culture and ESG

Jul 13, 2021 7:00am EDT

Recro Enters Development and Manufacturing Agreement With New Client

Jul 07, 2021 7:00am EDT

Recro Reports Inducement Grants for New Staff

Jun 16, 2021 7:00am EDT

Recro Appoints Laura L. Parks, Ph.D. to Board of Directors

Jun 02, 2021 7:00am EDT

Recro Expands Capabilities for Growing Clinical Trial Services (CTS) Offerings

May 18, 2021 7:00am EDT

Recro Enters Development Agreement With Astex Pharmaceuticals

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 24
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us